Abstract:Abstract Lung cancer is the leading cause of cancer related deaths worldwide, with the most prevalent subtype being non-small cell lung cancer (NSCLC). As only a subset of patients exhibits durable clinical responses to current treatments, including targeted therapy and immunotherapy, new treatment options are needed. Integrins (ITGs) are a diverse class of heterodimeric, transmembrane receptors that bind extracellularly to the extracellular matrix (ECM) and intracellularly to the cytoskeleton to integrate signals bi-directionally between the extracellular environment and cell interior. One of 18 α subunits is paired with one of 6 β subunits to create the 24 known αβ ITGs in mammals. ITGs are expressed at low levels in normal tissue and can be upregulated in cancer cells in response to stress signals in the tumor microenvironment (TME). Altered expression of ITGs is associated with enhanced cell proliferation, metastasis, and immune evasion. Targeting of the diverse ITG family members by inhibitors not specific to individual isoforms has obscured understanding of potentially distinct functions of each heterodimer. Through data mining of a genome wide CRISPR screening publicly available at the DepMap portal, we have identified a novel cancer dependency to ITG αvβ5 in approximately 40% of NSCLC cell lines. Using small molecule ITG αv inhibitors, we have mirrored sensitivity of NSCLC cell lines to their ITG αvβ5 CRISPR scores, suggesting that these inhibitors function specifically through ITG αvβ5 in cell lines. RNA sequencing analysis following αvβ5 inhibition in human NSCLC cell lines revealed downregulation of YAP and E2F1 target genes with alterations in gene ontologies associated with cell cycling and cell death in sensitive, but not resistant, lines. This is consistent with the known function of YAP driving gene transcription promoting cell proliferation and survival, and of E2F1 being implicated in regulating the proliferation and self-renewal of cancer stem cell (CSC). Additional changes to immune processes, specifically perturbations to interferon (IFN) pathways, were identified in response to ITG αvβ5 inhibition, suggesting that ITG αvβ5 may play a role in host anti-tumor immune responses. Pharmacological inhibition of ITG αvβ5 also led to a reduction of tumor growth in NSCLC murine models accompanied with increased CD8 T cell activation. These findings support ITG αvβ5 as a unique target of cancer dependency in NSCLC whose inhibition promotes anti-tumor responses through both tumor intrinsic and host immune regulatory mechanisms. Citation Format: Bitta P. Kahangi, William P. Crosson, Ji-Ann Lee, Camelia Dumitras, Tianhao Zhang, Ramin Salehi-Rad, Linh M. Tran, Michael Palazzolo, Dylan Conklin, Steven M. Dubinett, Bin Liu. Evaluation of integrin alpha v beta 5 as a novel target for non-small cell lung cancer via tumor intrinsic and host immune regulation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4266.

[Expression of the Integrin Alpha 6 Beta 4 and Effects of Integrin Alpha 6 Beta 4 on Adhesive and Invasive Behaviors of Human Laryngeal Carcinoma Cell Lines].

[Laminin and Its Alpha 6 Integrin Receptor in the Regulation of Human Hepatocellular Carcinoma Cell Phenotypes].

Effects of integrin αvβ6 on endo-exocytotic cycle of integrin αvβ5 in colon cancer cells

Expression and Significance of Integrins Subunits in Laryngeal Squamous Cell Carcinoma

The Inhibitory Effect of DLX4 RNAi on Adhesion and Invasion Ability of Choriocarcinoma Cells

Over Expression of Integrin Α 5 Β 1 in Human Hepatocellular Carcinoma Cell Line Suppresses Cell Proliferation in Vitro and Tumorigenicity in Nude Mice

The Interaction of HAb18G/CD147 with Integrin Α6β1 and Its Implications for the Invasion Potential of Human Hepatoma Cells

Expression of the Integrin Α 5 Subunit and Its Mediated Cell Adhesion in Hepatocellular Carcinoma

Expression of Interleukin-6 and Integrin ανβ6 in Colon Cancer: Association with Clinical Outcomes and Prognostic Implications

[Effects of Beta1-Integrin, Fibronectin and Laminin on Invasive Behavior of Human Gliomas].

Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma

In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix

The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma

The Role of Adhesion Molecules, Alpha V Beta 3, Alpha V Beta 5 and Their Ligands in the Tumor Cell and Endothelial Cell Adhesion

Basement Membrane Proteins Play an Active Role in the Invasive Process of Human Hepatocellular Carcinoma Cells with High Metastasis Potential

[Effects and Mechanisms of Fibronectin on Adhesion and Migration of Different Types of Lung Cancer Cell Lines].

Significant Role of Collagen XVII And Integrin β4 in Migration and Invasion of The Less Aggressive Squamous Cell Carcinoma Cells

The Roles of Integrin α5β1 in Human Cancer

Abstract 4266: Evaluation of integrin alpha v beta 5 as a novel target for non-small cell lung cancer via tumor intrinsic and host immune regulation

Integrin Alpha 6(High) Cell Population Functions As An Initiator In Tumorigenesis And Relapse Of Human Liposarcoma

Abstract 6528: Integrin ɑvβ6 upregulation as a mechanism of T-cell evasion in head and neck squamous cell carcinoma